VISTAGEN THERAPEUTICS, INC. Operating Lease Liability
VISTAGEN THERAPEUTICS, INC. (VTGN) had Operating Lease Liability of $948.00 thousand as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-06-15
- 2026-03-31: Operating Lease, Liability $948.00K.
- 2025-03-31: Operating Lease, Liability $1.51M.
- 2024-03-31: Operating Lease, Liability $2.12M.
- 2023-06-30: Operating Lease, Liability $2.49M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-03-31 | $948.00K 10-K · filed 2026-06-15 |
| 2025-03-31 | $1.51M 10-K · filed 2025-06-17 |
| 2024-03-31 | $2.12M 10-K · filed 2024-06-11 |
| 2023-06-30 | $2.49M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.61M 10-Q · filed 2023-08-10 |
| 2022-12-31 | $2.72M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $2.83M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.93M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.04M 10-K · filed 2023-06-28 |
| 2021-12-31 | $3.14M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $3.54M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.63M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.72M 10-K · filed 2022-06-23 |
| 2020-12-31 | $3.80M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $3.88M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.96M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $4.03M 10-K · filed 2021-06-29 |
| 2019-12-31 | $4.10M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $4.17M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.24M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |